Evidence map›Paper›PMID 25487526›Full record

ArticleNature communications2014

Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions.

Swantje Liedmann, Eike R Hrincius, Cliff Guy, Darisuren Anhlan, Rüdiger Dierkes, Robert Carter, Gang Wu, Peter Staeheli, Douglas R Green, Thorsten Wolff and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Multi-spectral Fluorescent Reporter Influenza A Viruses Allow forbioRxiv : the preprint server for biology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Roles of Ubiquitination in Pathogenesis of Influenza Virus Infection.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Swantje LiedmannInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Von-Esmarch-Street 56, D-48149 Muenster, Germany.
Eike R HrinciusDepartment of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA.
Cliff GuyDepartment of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA.
Darisuren AnhlanInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Von-Esmarch-Street 56, D-48149 Muenster, Germany.
Rüdiger DierkesInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Von-Esmarch-Street 56, D-48149 Muenster, Germany.
Robert CarterDepartment of Computational Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA.
Gang WuDepartment of Computational Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA.
Peter StaeheliInstitute of Virology, University Medical Center Freiburg, Hermann-Herder-Street 11, D-79104 Freiburg, Germany.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA.
Thorsten WolffDivision of Influenza and Other Respiratory Viruses, Seestraβe 10, Robert Koch-Institut, D-13353 Berlin, Germany.
Jonathan A McCullers1] Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678, USA [2] Department of Pediatrics, University of Tennessee Health Sciences Center, 50 N. Dunlap, Memphis, Tennessee 38103, USA.
Stephan Ludwig1] Institute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Von-Esmarch-Street 56, D-48149 Muenster, Germany [2] Cluster of Excellence Cells in Motion, University of Muenster, Muenster, Germany.
Christina Ehrhardt1] Institute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Von-Esmarch-Street 56, D-48149 Muenster, Germany [2] Cluster of Excellence Cells in Motion, University of Muenster, Muenster, Germany.
St. Jude Children's Research Hospital · USInstitute of Molecular Biology · DERobert Koch Institute · DEUniversity Medical Center Freiburg · DEUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Survival Function of the Fadd-Caspase-8-Flip ComplexR01AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1999 to 2016
$6.3M
NCI NIH HHS P30 CA021765NIAID NIH HHS R01 AI044828
6 · The paper itself

Abstract

The type I interferon (IFN) response represents the first line of defence to invading pathogens. Internalized viral ribonucleoproteins (vRNPs) of negative-strand RNA viruses induce an early IFN response by interacting with retinoic acid inducible gene I (RIG-I) and its recruitment to mitochondria. Here we employ three-dimensional stochastic optical reconstruction microscopy (STORM) to visualize incoming influenza A virus (IAV) vRNPs as helical-like structures associated with mitochondria. Unexpectedly, an early IFN induction in response to vRNPs is not detected. A distinct amino-acid motif in the viral polymerases, PB1/PA, suppresses early IFN induction. Mutation of this motif leads to reduced pathogenicity in vivo, whereas restoration increases it. Evolutionary dynamics in these sequences suggest that completion of the motif, combined with viral reassortment can contribute to pandemic risks. In summary, inhibition of the immediate anti-viral response is 'pre-packaged' in IAV in the sequences of vRNP-associated polymerase proteins.

Indexed as

Amino Acid MotifsAnimalsCell Line, TumorDEAD Box Protein 58DEAD-box RNA HelicasesEvolution, MolecularFemaleHumansImaging, Three-DimensionalInfluenza A virusInterferon Type ILungMaleMiceMice, Inbred BALB CMice, Inbred C57BLDdx58 protein, mouseDEAD Box Protein 58DEAD-box RNA Helicasesinfluenza virus polymerase basic protein 1Interferon Type IReceptors, ImmunologicRIGI protein, humanViral Proteins

Identifiers

PMID25487526
PMCPMC4268707
OpenAlexW2050834852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.